Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Cardiol Therapeutics (CRDL)

Annual Return

Over the past 3 years, CRDL has had an average annual return of +9.16%, underperforming the benchmark SPY, which returned +20.51% annual.

Over the past 5 years, CRDL has had an average annual return of -16.29%, underperforming the benchmark SPY, which returned +13.50% annual.

Since Jan 15, 2019, CRDL has had an average annual return of -15.97%, underperforming the benchmark SPY, which returned +16.89% annual.

20262025202420232022202120202019
+8%-25.49%+51.77%+65.37%-72.43%-15.14%-38.36%-5.49%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-0.31%+7.28%+32.36%+2.22%-11.58%-15.58%+8%
2025+10.14%-18.42%-15.68%+13.43%+13.64%+8.80%+9.55%-27.52%-0.90%+5.59%-7.09%-9.16%-25.49%
2024+44.68%+68.84%-12.13%+11.04%+30.34%-22.89%+6.93%-10.19%+2.06%-9.09%-10.00%-20.99%+51.77%
2023+38.08%-24.65%-8.18%+27.19%+8.82%+32.02%+21.31%+1.87%-18.64%-7.27%+10.41%-7.96%+65.37%
2022+0%-9.18%-8.93%-10.44%-2.21%-1.48%-0%-15.16%-8.02%-41.88%-13.94%-1.02%-72.43%
2021+12.86%+41.87%+0.28%-1.42%-21.16%-11.77%-6.25%+66.24%+10.96%-12.77%-44.75%-7.50%-15.14%
2020-14.03%-24.90%-10.50%+2.78%-3.81%-13.41%+1.75%+26.97%+0.45%-1.10%-8.67%+6.31%-38.36%
2019+19.20%+33.41%-29.41%+0.95%-29.63%+13.07%+6.72%-10.95%-26.75%+3.06%+25.82%+16.13%-5.49%

Drawdown analysis of Cardiol Therapeutics (CRDL)

The maximum drawdown for the CRDL was -92.72%, occurring on Apr 5, 2023. This drawdown has not yet recovered.

The current CRDL drawdown is -83.36%.

Since Jan 15, 2019 CRDL has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-92.72%Feb 22, 20191037Apr 5, 2023OngoingOngoingOngoing
-9.26%Feb 4, 20193Feb 7, 20197Feb 19, 201910
-1.86%Jan 18, 20192Jan 23, 20192Jan 29, 20194
-0.20%Jan 16, 20191Jan 17, 20191Jan 18, 20192